CVS, Express Scripts, OptumRx face amended US complaint over drug prices
MLex Summary: Plaintiffs filed an amended US complaint accusing CVS, Express Scripts and OptumRx of manipulating the US pharmaceutical market to inflate drug prices and restrict competition, thereby causing patients and third-party...To view the full article, register now.
Already a subscriber? Click here to view full article